The impact of anemia and its treatment on patients with gynecologic malignancies

被引：32

作者：

Campos, S ^{[1
]}

机构：

[1] Dana Farber Canc Ctr, Dept Med Oncol, Boston, MA 02115 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 03期

关键词：

D O I：

10.1053/sonc.2002.33526

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：7 / 12

页数：6

共 35 条

[1] ERYTHROPOIETIN FOR ANEMIA IN CANCER-PATIENTS [J].

ABELS, R .

EUROPEAN JOURNAL OF CANCER, 1993, 29A :S2-S8

[2] IMPROVED THERAPEUTIC INDEX OF CARBOPLATIN PLUS CYCLOPHOSPHAMIDE VERSUS CISPLATIN PLUS CYCLOPHOSPHAMIDE - FINAL REPORT BY THE SOUTHWEST-ONCOLOGY-GROUP OF A PHASE-III RANDOMIZED TRIAL IN STAGE-III AND STAGE-IV OVARIAN-CANCER [J].

ALBERTS, DS ;

GREEN, S ;

HANNIGAN, EV ;

OTOOLE, R ;

STOCKNOVACK, D ;

ANDERSON, P ;

SURWIT, EA ;

MALVLYA, VK ;

NAHHAS, WA ;

JOLLES, CJ .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (05) :706-717

[3] Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer [J].

Alberts, DS ;

Liu, PY ;

Hannigan, EV ;

OToole, R ;

Williams, SD ;

Young, JA ;

Franklin, EW ;

ClarkePearson, DL ;

Malviya, VK ;

DuBeshter, B ;

Adelson, MD ;

Hoskins, WJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) :1950-1955

[4]

Beltangady M, 1990, CARBOPLATIN JM 8 CUR, P175

[5]

CLEELAND CS, 1999, P AN M AM SOC CLIN, V18, pA574

[6] Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: Results of a large European phase II study [J].

Creemers, GJ ;

Bolis, G ;

Gore, M ;

Scarfone, G ;

Lacave, AJ ;

Guastalla, JP ;

Despax, R ;

Favalli, G ;

Kreinberg, R ;

VanBelle, S ;

Hudson, I ;

Verweij, J ;

Huinink, WWT .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (12) :3056-3061

[7]

CURT GA, 1999, P AN M AM SOC CLIN, V18, pA573

[8]

DEMETRI G, 1999, INT GYNECOLOGIC C S1, V9, P151

[9] Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study [J].

Demetri, GD ;

Kris, M ;

Wade, J ;

Degos, L ;

Cella, D .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3412-3425

[10] PHASE-II STUDY AND LONG-TERM FOLLOW-UP OF PATIENTS TREATED WITH TAXOL FOR ADVANCED OVARIAN ADENOCARCINOMA [J].

EINZIG, AI ;

WIERNIK, PH ;

SASLOFF, J ;

RUNOWICZ, CD ;

GOLDBERG, GL .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (11) :1748-1753

← 1 2 3 4 →